Clinical trial
N2001-02: I-MIBG With Intensive Chemotherapy and Autologous Stem Cell Rescue for…
NCT00253435 · Children's Hospital Los Angeles, Other · Completed
Key facts
| NCT number | NCT00253435 |
|---|---|
| Title | N2001-02: I-MIBG With Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma |
| Official title | I-Metaiodobenzylguanidine (MIBG) With Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma |
| Lead sponsor | Children's Hospital Los Angeles, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Neuroblastoma |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | Filgrastim, Carboplatin, Etoposide, Melphalan, Peripheral blood stem cell infusion, 131I-MIBG, Radiation therapy |
| Enrollment | 50 |
| Start date | Sep 1, 2005 |
| Primary completion | Dec 1, 2012 |
| Completion | Dec 1, 2013 |
| First posted | Nov 15, 2005 |
| Last update posted | Apr 10, 2023 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: